Modulating LCK activity via USP11 silencing or USP7 inhibition sensitized T-ALL cells to the GC treatment, as evidenced by inhibition of cell growth caused by an increase in apoptosis upon GC treatment (fig. This evidence concerns the gene USP11 and acute lymphoblastic leukemia.